A study of the effectiveness and safety of pars plana vitrecotmy with subretinal oxiglutatione injection for the treatment of refractory macular edema

A study of the effectiveness and safety of pars plana vitrecotmy with subretinal oxiglutatione injection for the treatment of refractory macular edema - Subretinal oxiglutatione injection for the treatment of macular edema

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015962

Enrollment

Registered

2015-01-01

Start date

2015-01-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

macular edema

Interventions

Pars plana vitrecotmy with subretinal oxiglutatione injection is performed.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patients with macular edema who are under hospitalization or going to hospital regularly

Exclusion criteria

Exclusion criteria: (1) the patients who refused the consent for this study (2) the patient judged to be unsuitable for study participation by doctor in charge

Design outcomes

Primary

Measure	Time frame
visual acuity improvement at postoperative 6 months	—

Secondary

Measure	Time frame
change of the following parameters at postoperative 6 months from the baseline: (1) macular thickness measured by optical coherence tomography, (2) visual field, (3) electroretinogram	—

Countries

Japan

Contacts

Public ContactSentaro Kusuhara

Kobe University Graduate School of Medicine Division of Ophthalmology, Department of Surgery

kusu@med.kobe-u.ac.jp078-382-6048

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026